RecruitingNCT07029984

Baylor Continence Scale Validity in Anorectal Malformation

Baylor Continence Scale in Children With Anorectal Malformations: A Turkish Validity and Reliability Study


Sponsor

Izmir Bakircay University

Enrollment

230 participants

Start Date

May 10, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to evaluate the validity and reliability of the Baylor Continence Scale in Turkish-speaking children diagnosed with anorectal malformations. The scale is used to assess continence levels, helping healthcare providers make informed decisions regarding treatment and follow-up. The study includes a sample of children with confirmed anorectal malformations, and data collection consists of language adaptation, statistical validation, and reliability testing. Results will contribute to the standardization of continence assessment in Turkish clinical settings, ensuring accurate evaluations for pediatric patients.


Eligibility

Min Age: 6 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Baylor Continence Scale for people with anorectal malformations. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBaylor Continence Scale

This study may be one of the first to test the Turkish adaptation and validity of the scale in Turkish children with anorectal malformations.


Locations(1)

Ege University Department of Pediatric Surgery and Bakırçay University Physical Therapy and Rehabilitation Application and Research Center

Izmir, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07029984


Related Trials